About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Bioequivalency Study of 7.5 mg Pilocarpine Under Fed Conditions

Bioequivalency Study of 7.5 mg Pilocarpine Under Fed Conditions

NCT00618059·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Roxane Laboratories

Age

18–45

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

No clinically significant abnormal findings on the physical examination, medical history, or clinical laboratory results during screening.

You may not be if

Positive test for HIV, Hepatitis B, or Hepatitis C.
Treatment with known enzyme altering drugs.
History of allergic or adverse response to Pilocarpine or any comparable or similar product.

The record

StatusCompleted

PhaseNo phase

Taking part28

StartedAug 2004

UpdatedJan 23, 2018

Conditions

Where1

CEDRA Clinical Research, LLC
Austin, Texas, United States